The investigational tuberculosis vaccine M72/AS01E-4 has an acceptable safety profile and robust immunogenicity among ...

A London-wide HIV charity has said it could be forced to close if the funding crisis it is facing continues. Positively UK, ...

Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...

Lori Cannon, a renowned Chicago activist and advocate for Chicago's LGBTQ+ community and people living with HIV/AIDS, died ...

Receiving treatment within the first month of life could protect children for at least three years, a study suggests.

A single shot of gene therapy given to newborn monkeys appears to shield them from HIV, the virus that causes AIDS, for at ...

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

Despite decades of medical progress, HIV continues to devastate Black communities. The statistics are sobering. The disparities, undeniable.

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

According to the Kaiser Family Foundation, the CDC funds 91% of domestic HIV prevention efforts. It represents a $794 million ...

Scientists in Japan have discovered a genetic "silencer" within the HTLV-1 virus that helps it stay hidden in the body, ...